On December 9, 2021, the Treatment Council (Behandlingsråd), during its meeting, approved three topics selected for developing the so-called major analyses (større analyser) in 2022. The approved topics include handheld focused ultrasound in emergency medicine, artificial intelligence (AI) as decision support for colonoscopy, and intelligent/high-tech beds for use in intensive care units.
The analysis on the topic of handheld focused ultrasound in emergency medicine is intended to examine how handheld, pocket-sized ultrasound equipment should be introduced for focused point-of-care ultrasound examinations in emergency rooms.
The analysis concerning AI as decision support for colonoscopy is aimed to answer two research questions:
- Should additional, AI-based, real-time decision support be used in colonoscopic examinations for colorectal cancer - and if so
- Are there any significant differences between AI-based, real-time, decision support tools for use in colorectal cancer colonoscopic examinations.
The fourth proposed topic was dedicated to patient-centered diabetes technology. During the meeting, it was decided to limit the analysis to the use of glucose meters in adults with type 1 diabetes and commissioned the Chairman of the Council together with the future chair of the relevant professional committee to further qualify and define the final proposal for the analysis.
The Treatment Council is a new body for assessing treatments and health technologies that became fully operational in late May 2021. The Treatment Council is expected to prepare 2-3 major analyses annually. The analyses are based on more fundamental topics concerning treatment regimens or approaches or organization of treatment. Based on the received proposals, the Board of the Danish Regions selects 2-3 analysis topics once a year, which constitute the Council's annual program for major analyses.
The full details in Danish can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.